Skip to content

CATER: Comprehensive Alveolar and Tooth Esthetic Replacement

CATER: Comprehensive Alveolar and Tooth Esthetic Replacement

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04082143
Acronym
CATER
Enrollment
39
Registered
2019-09-09
Start date
2019-08-25
Completion date
2022-12-20
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant Failure Nos

Brief summary

The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm\*) during dental implant therapy improves implant health and appearance. On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplemental gum graft along with the implant. Participating subjects will also be asked to complete a brief (about 15 questions) oral health questionnaire. Participating subjects will return to the clinic about 8 weeks post surgery for digital crown impressions and again at 11-13 weeks after surgery for crown placement. Participating subjects will also return to clinic at 1 year after implant placement for implant evaluation. At this final study appointment, x-rays and a 3D intraoral scan will be obtained for the purpose of measuring alveolar volume. The health of the mucosa surrounding the implant and subject satisfaction will be assessed via bleeding upon probing and completion of a brief questionnaire, respectively.

Detailed description

An alveolar ridge is the part of the jawbone which immediately surrounds and anchors the tooth socket (alveolus). Similar to any bone or muscle atrophying when not used, the alveolar ridge will shrink (resorb) following tooth extraction. The volume of an alveolar ridge can be measured by both 3 Dimensional (3D) intraoral scan and radiography, and is used clinically as a metric of oral health. A dental implant is a medical-grade titanium screw placed into healed alveolar bone or a tooth socket following tooth extraction. It replaces the tooth root and supports the crown, or dental cap; an artificial tooth generally made with porcelain or surgical grade metals. Implant success requires both sufficient bone alveolar volume and sufficient mucosal tissue to protect against biofilm-mediated inflammation, assure functional comfort and contribute to dental implant esthetics. Following dental implant placement, the alveolar ridge resorbs approximately 0.5 to 1.0 mm during the first year. Healed ridges are also often volumetrically deficient, losing up to 30% of their horizontal volume following tooth extraction. To remedy this, peri-implant mucosal grafting has been proposed and is currently part of dental implant therapy. Both autogenous grafts (mucosal connective tissue from the roof of the patient's own mouth or palate) and allogeneic grafts (collagen-rich grafts derived from a genetically non-identical human donor) are used for these purposes, but there is controversy regarding the effectiveness of supplemental graft use during implant treatment. The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm\*) during dental implant therapy improves implant health and appearance. On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplemental gum allograft along with the implant. Participating subjects will also be asked to complete a brief (about 15 questions) oral health questionnaire. Participating subjects will return to the clinic about 8 weeks post surgery for digital crown impressions and again at 11-13 weeks after surgery for crown placement. Participating subjects will also return to clinic about 1 year after implant placement for assessment of the implant evaluation. At this final study appointment, x-rays, a 3D intraoral scan and intraoral photographs of the implant will be obtained for the purpose of measuring alveolar volume. The health of the mucosa surrounding the implant and subject satisfaction will be measured via bleeding upon probing and completion of a brief questionnaire, respectively.

Interventions

DEVICEAllograft mucosal enhancement with dental implant

implant placement with allograft mucosal enhancement

DEVICENo allograft mucosal enhancement at time of dental implant placement

implant placement without allograft mucosal enhancement

Sponsors

Dentsply Sirona Implants and Consumables
CollaboratorINDUSTRY
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

subjects will be randomized to one of two groups

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * Willing and able to provide informed consent * In need of one implant to replace a missing tooth * At least 20 teeth in good repair and occlusion * Sufficient bone volume for dental implant placement without required bone augmentation * Site development (soft and/or bone tissue) performed at least 5 months before implant placement, when required

Exclusion criteria

* Current smoker * Implant cannot be placed without bone graft * Unable to pay for crown * Untreated rampant caries and/or uncontrolled periodontitis * Absence of adjacent (mesial and/or distal) natural tooth * Uncontrolled diabetes * Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration * use of bisphosphonates * History of radiation in the head and neck region * Unable or unwilling to return for follow-up visits * Unrealistic esthetic or functional demands * Unlikely to be able to comply with study procedures * Unwilling or unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Percent Change in Volume of Alveolar Ridge as Measured by 3D Intraoral Scanning12 months post implant surgeryVolume of the alveolar ridge (percentage change of the volume) as measured by 3D Intraoral scanning

Secondary

MeasureTime frameDescription
Percentage of Implant Survival12 months post implant surgeryImplant survival at 12 months post implant surgery. Percentage of implants surviving after 12 months of placement
Marginal Bone Levels (MBLs)12 months post implant surgeryMarginal bone levels (in millimeters) as measured by radiographic translucency. Bone levels between implant/abutment interface and crest of the bone were measured at time of implant placement and at 12 months later. The negative sign in the results below indicates that there was bone loss in both groups.
Vertical Tissue Change as Measured by 3D Intraoral Scanning12 months post surgeryThis measurement is for the vertical position of the gingival margin change based on superimposed 3D intraoral scans

Other

MeasureTime frameDescription
Patient Satisfaction12 months post implant surgeryPatient satisfaction with implant therapy as measured by the Oral Health Impact Profile

Countries

United States

Participant flow

Recruitment details

The target was to recruit a total of 40 participants (20 for each group) and up to 60 as a maximum. The number that was eventually enrolled in the study was 39.

Participants by arm

ArmCount
Implant With Prophylactic Allograft
Allograft mucosal enhancement with dental implant: implant placement with allograft mucosal enhancement
19
Implant Without Prophylactic Allograft
No allograft mucosal enhancement at time of dental implant placement: implant placement without allograft mucosal enhancement
20
Total39

Baseline characteristics

CharacteristicImplant Without Prophylactic AllograftTotalImplant With Prophylactic Allograft
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants8 Participants4 Participants
Age, Categorical
Between 18 and 65 years
16 Participants31 Participants15 Participants
Age, Continuous53.1 years
STANDARD_DEVIATION 2
52.8 years
STANDARD_DEVIATION 3
51.1 years
STANDARD_DEVIATION 3
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
20 participants39 participants19 participants
Sex: Female, Male
Female
12 Participants22 Participants10 Participants
Sex: Female, Male
Male
8 Participants17 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 20
other
Total, other adverse events
0 / 190 / 20
serious
Total, serious adverse events
0 / 190 / 20

Outcome results

Primary

Percent Change in Volume of Alveolar Ridge as Measured by 3D Intraoral Scanning

Volume of the alveolar ridge (percentage change of the volume) as measured by 3D Intraoral scanning

Time frame: 12 months post implant surgery

ArmMeasureValue (MEAN)Dispersion
Implant With Prophylactic AllograftPercent Change in Volume of Alveolar Ridge as Measured by 3D Intraoral Scanning15.5 percentage of volume changeStandard Deviation 19
Implant Without Prophylactic AllograftPercent Change in Volume of Alveolar Ridge as Measured by 3D Intraoral Scanning16.8 percentage of volume changeStandard Deviation 62
Secondary

Marginal Bone Levels (MBLs)

Marginal bone levels (in millimeters) as measured by radiographic translucency. Bone levels between implant/abutment interface and crest of the bone were measured at time of implant placement and at 12 months later. The negative sign in the results below indicates that there was bone loss in both groups.

Time frame: 12 months post implant surgery

ArmMeasureValue (MEAN)Dispersion
Implant With Prophylactic AllograftMarginal Bone Levels (MBLs)-0.17 mmStandard Deviation 0.33
Implant Without Prophylactic AllograftMarginal Bone Levels (MBLs)-0.01 mmStandard Deviation 0.11
Secondary

Percentage of Implant Survival

Implant survival at 12 months post implant surgery. Percentage of implants surviving after 12 months of placement

Time frame: 12 months post implant surgery

Population: Two implants in the group (Implant without prophylactic allograft failed resulting in a 90% survival rate in that group and 95% overall survival rate for the study.

ArmMeasureValue (NUMBER)
Implant With Prophylactic AllograftPercentage of Implant Survival100 Percentage
Implant Without Prophylactic AllograftPercentage of Implant Survival90 Percentage
Secondary

Vertical Tissue Change as Measured by 3D Intraoral Scanning

This measurement is for the vertical position of the gingival margin change based on superimposed 3D intraoral scans

Time frame: 12 months post surgery

ArmMeasureValue (MEAN)Dispersion
Implant With Prophylactic AllograftVertical Tissue Change as Measured by 3D Intraoral Scanning0.18 mmStandard Deviation 0.27
Implant Without Prophylactic AllograftVertical Tissue Change as Measured by 3D Intraoral Scanning0.16 mmStandard Deviation 0.31
Other Pre-specified

Patient Satisfaction

Patient satisfaction with implant therapy as measured by the Oral Health Impact Profile

Time frame: 12 months post implant surgery

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026